Find Clinical Trial

Detralex* versus placebo in the treatment of acute hemorrhoids in patients with acute hemorrhoidal attack. One week, double-blind, randomized, placebo controlled, multicentre study. HEMODEX study


← Back
Study Phase

Phase 4

Therapeutic Area

Cardiovascular Diseases

Active substance/
Medical device

MICRONISED PURIFIED FLAVONOID FRACTION

SponsorServier s.r.o.
Active Substance CodeS005682
Protocol CodeIC4-05682-031
EudraCT Code2004-002707-32


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.
Accessibility